TPG GP A, LLC purchased 20.2% of their position (1.13M shares) of SIONNA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $20.25M — a significant purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+4.88M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.13M
Price / share
$18.00
Trade value
$20.25M
% of position
Net shares
+6M
Net value
$20.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/10/2025 | C · Conversion | +4.88M | — | — | 712.4% | 684.41K | 5.56M |
| Common Stock Indirect | 2/10/2025 | P · Purchase | +1.13M | $18.00 | $20.25M | 20.2% | 5.56M | 6.68M |
| Total | +6M | $20.25M | ||||||
Series Seed Preferred Stock
Common Stock
873.50K shares
Shares
−1.28M
Strike price
Held after
0.00
Exercisable
—
Series A Preferred Stock
Common Stock
1.24M shares
Shares
−1.81M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
1.56M shares
Shares
−2.28M
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Common Stock
1.21M shares
Shares
−1.77M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series Seed Preferred Stock Indirect | Common Stock873.50K shares | 2/10/2025 | C · Conversion | −1.28M | — | 0.00 | |
| Series A Preferred Stock Indirect | Common Stock1.24M shares | 2/10/2025 | C · Conversion | −1.81M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock1.56M shares | 2/10/2025 | C · Conversion | −2.28M | — | 0.00 | |
| Series C Preferred Stock Indirect | Common Stock1.21M shares | 2/10/2025 | C · Conversion | −1.77M | — | 0.00 |